Advance in Targeted Cancer Therapy and Mechanisms of Resistance
- Clinical discovery
- Resistance mechanisms
- Novel therapeutics
- Summary
Acknowledgments
Conflicts of Interest
References
- Chung, J.Y.; Tang, P.C.; Chan, M.K.; Xue, V.W.; Huang, X.R.; Ng, C.S.; Zhang, D.; Leung, K.T.; Wong, C.K.; Lee, T.L.; et al. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nat. Commun. 2023, 14, 1794. [Google Scholar] [CrossRef] [PubMed]
- Chan, M.K.; Chung, J.Y.; Tang, P.C.; Chan, A.S.; Ho, J.Y.; Lin, T.P.; Chen, J.; Leung, K.T.; To, K.F.; Lan, H.Y.; et al. TGF-beta signaling networks in the tumor microenvironment. Cancer Lett. 2022, 550, 215925. [Google Scholar] [CrossRef] [PubMed]
- Basse, C.; Trabelsi-Grati, O.; Masliah, J.; Callens, C.; Kamal, M.; Freneaux, P.; Klijanienko, J.; Bieche, I.; Girard, N. Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2023, 24, 3802. [Google Scholar] [CrossRef] [PubMed]
- Aptullahoglu, E.; Wallis, J.P.; Marr, H.; Marshall, S.; Bown, N.; Willmore, E.; Lunec, J. SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2023, 24, 11335. [Google Scholar] [CrossRef] [PubMed]
- Pitts, H.A.; Cheng, C.K.; Cheung, J.S.; Sun, M.K.; Yung, Y.L.; Chan, H.Y.; Wong, R.S.M.; Yip, S.F.; Lau, K.N.; Wong, W.S.; et al. SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response. Int. J. Mol. Sci. 2023, 24, 9696. [Google Scholar] [CrossRef] [PubMed]
- Gan, X.; Li, S.; Wang, Y.; Du, H.; Hu, Y.; Xing, X.; Cheng, X.; Yan, Y.; Li, Z. Aspartate beta-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer. Int. J. Mol. Sci. 2023, 24, 5482. [Google Scholar] [CrossRef] [PubMed]
- Martinez, S.R.; Elix, C.C.; Ochoa, P.T.; Sanchez-Hernandez, E.S.; Alkashgari, H.R.; Ortiz-Hernandez, G.L.; Zhang, L.; Casiano, C.A. Glucocorticoid Receptor and beta-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance. Int. J. Mol. Sci. 2023, 24, 7130. [Google Scholar] [CrossRef] [PubMed]
- Chong, K.H.; Chang, Y.J.; Hsu, W.H.; Tu, Y.T.; Chen, Y.R.; Lee, M.C.; Tsai, K.W. Breast Cancer with Increased Drug Resistance, Invasion Ability, and Cancer Stem Cell Properties through Metabolism Reprogramming. Int. J. Mol. Sci. 2022, 23, 12875. [Google Scholar] [CrossRef] [PubMed]
- Huang, G.; Chen, S.; Washio, J.; Paka Lubamba, G.; Takahashi, N.; Li, C. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/beta-Catenin Signaling Pathway. Int. J. Mol. Sci. 2023, 24, 1992. [Google Scholar] [CrossRef] [PubMed]
- Moon, D.O. Calcium’s Role in Orchestrating Cancer Apoptosis: Mitochondrial-Centric Perspective. Int. J. Mol. Sci. 2023, 24, 8982. [Google Scholar] [CrossRef] [PubMed]
- Tang, P.C.; Chung, J.Y.; Liao, J.; Chan, M.K.; Chan, A.S.; Cheng, G.; Li, C.; Huang, X.R.; Ng, C.S.; Lam, E.W.; et al. Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain. Sci. Adv. 2022, 8, eabn5535. [Google Scholar] [CrossRef] [PubMed]
- Tang, P.C.; Chung, J.Y.; Xue, V.W.; Xiao, J.; Meng, X.M.; Huang, X.R.; Zhou, S.; Chan, A.S.; Tsang, A.C.; Cheng, A.S.; et al. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition. Adv. Sci. 2022, 9, e2101235. [Google Scholar] [CrossRef] [PubMed]
- Chan, M.K.; Chan, E.L.; Ji, Z.Z.; Chan, A.S.; Li, C.; Leung, K.T.; To, K.F.; Tang, P.M. Transforming growth factor-beta signaling: From tumor microenvironment to anticancer therapy. Explor. Target. Antitumor Ther. 2023, 4, 316–343. [Google Scholar] [CrossRef] [PubMed]
- Brandt, B.; Nemeth, M.; Berta, G.; Szunstein, M.; Heffer, M.; Rauch, T.A.; Pap, M. A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines. Int. J. Mol. Sci. 2023, 24, 7929. [Google Scholar] [CrossRef] [PubMed]
- Chung, J.Y.; Chan, M.K.; Tang, P.C.; Chan, A.S.; Chung, J.S.; Meng, X.M.; To, K.F.; Lan, H.Y.; Leung, K.T.; Tang, P.M. AANG: A natural compound formula for overcoming multidrug resistance via synergistic rebalancing the TGF-beta/Smad signalling in hepatocellular carcinoma. J. Cell Mol. Med. 2021, 25, 9805–9813. [Google Scholar] [CrossRef] [PubMed]
- Luo, Q.; Jia, L.; Huang, C.; Qi, Q.; Jahangir, A.; Xia, Y.; Liu, W.; Shi, R.; Tang, L.; Chen, Z. Polyphyllin I Promotes Autophagic Cell Death and Apoptosis of Colon Cancer Cells via the ROS-Inhibited AKT/mTOR Pathway. Int. J. Mol. Sci. 2022, 23, 9368. [Google Scholar] [CrossRef] [PubMed]
- Elgohary, S.; Eissa, R.A.; El Tayebi, H.M. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. Int. J. Mol. Sci. 2023, 24, 14254. [Google Scholar] [CrossRef] [PubMed]
- Kang, M.A.; Rao, P.P.; Matsui, H.; Mahajan, S.S. Delivery of mGluR5 siRNAs by Iron Oxide Nanocages by Alternating Magnetic Fields for Blocking Proliferation of Metastatic Osteosarcoma Cells. Int. J. Mol. Sci. 2022, 23, 7944. [Google Scholar] [CrossRef] [PubMed]
- Jarvelainen, H.A.; Schmithals, C.; von Harten, M.; Kakoschky, B.; Vogl, T.J.; Harris, S.; Henson, C.; Bullen-Clerkson, G.; Piiper, A. Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1. Int. J. Mol. Sci. 2023, 24, 5700. [Google Scholar] [CrossRef]
- Xue, V.W.; Chung, J.Y.; Tang, P.C.; Chan, A.S.; To, T.H.; Chung, J.S.; Mussal, F.; Lam, E.W.; Li, C.; To, K.F.; et al. USMB-shMincle: A virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages. Mol. Ther. Oncolytics 2021, 23, 26–37. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tang, P.M.-K.; Zhang, D. Advance in Targeted Cancer Therapy and Mechanisms of Resistance. Int. J. Mol. Sci. 2023, 24, 16584. https://doi.org/10.3390/ijms242316584
Tang PM-K, Zhang D. Advance in Targeted Cancer Therapy and Mechanisms of Resistance. International Journal of Molecular Sciences. 2023; 24(23):16584. https://doi.org/10.3390/ijms242316584
Chicago/Turabian StyleTang, Patrick Ming-Kuen, and Dongmei Zhang. 2023. "Advance in Targeted Cancer Therapy and Mechanisms of Resistance" International Journal of Molecular Sciences 24, no. 23: 16584. https://doi.org/10.3390/ijms242316584